Index by author
October 01, 2021; Volume 49,Issue 10
A
Anoshchenko, Olena
- Open AccessSuccessful Prediction of Human Fetal Exposure to P-Glycoprotein Substrate Drugs Using the Proteomics-Informed Relative Expression Factor Approach and PBPK Modeling and SimulationOlena Anoshchenko, Flavia Storelli and Jashvant D. UnadkatDrug Metabolism and Disposition October 2021, 49 (10) 919-928; DOI: https://doi.org/10.1124/dmd.121.000538
B
Beers, Jessica L.
- You have accessCytochrome P450–Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-CannabidiolJessica L. Beers, Dong Fu and Klarissa D. JacksonDrug Metabolism and Disposition October 2021, 49 (10) 882-891; DOI: https://doi.org/10.1124/dmd.120.000350
Biller, Scott A.
- You have accessPreclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V. Nagaraja, Bin Fan, Luke Utley, Rene M. Lemieux, Janeta Popovici-Muller, Lenny Dang, Hyeryun Kim, Liping Yan, Shin-San M. Su, Scott A. Biller and Hua YangDrug Metabolism and Disposition October 2021, 49 (10) 870-881; DOI: https://doi.org/10.1124/dmd.120.000234
Bow, Daniel A.J.
- You have accessQuantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin DispositionRyota Kikuchi, William J. Chiou, Kenneth R. Durbin, John P. Savaryn, Junli Ma, Arian Emami Riedmaier, Sonia M. de Morais, Gary J. Jenkins and Daniel A.J. BowDrug Metabolism and Disposition October 2021, 49 (10) 938-946; DOI: https://doi.org/10.1124/dmd.121.000487
C
Cerny, Matthew A.
- You have accessStatic and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and HepatocytesElaine Tseng, Heather Eng, Jian Lin, Matthew A. Cerny, David A. Tess, Theunis C. Goosen and R. Scott ObachDrug Metabolism and Disposition October 2021, 49 (10) 947-960; DOI: https://doi.org/10.1124/dmd.121.000497
Chen, Xin
- You have accessTetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2)Xin Chen, Jashvant D. Unadkat and Qingcheng MaoDrug Metabolism and Disposition October 2021, 49 (10) 910-918; DOI: https://doi.org/10.1124/dmd.121.000505
Chen, Yue
- You have accessPreclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V. Nagaraja, Bin Fan, Luke Utley, Rene M. Lemieux, Janeta Popovici-Muller, Lenny Dang, Hyeryun Kim, Liping Yan, Shin-San M. Su, Scott A. Biller and Hua YangDrug Metabolism and Disposition October 2021, 49 (10) 870-881; DOI: https://doi.org/10.1124/dmd.120.000234
Chiou, William J.
- You have accessQuantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin DispositionRyota Kikuchi, William J. Chiou, Kenneth R. Durbin, John P. Savaryn, Junli Ma, Arian Emami Riedmaier, Sonia M. de Morais, Gary J. Jenkins and Daniel A.J. BowDrug Metabolism and Disposition October 2021, 49 (10) 938-946; DOI: https://doi.org/10.1124/dmd.121.000487
D
Dang, Lenny
- You have accessPreclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V. Nagaraja, Bin Fan, Luke Utley, Rene M. Lemieux, Janeta Popovici-Muller, Lenny Dang, Hyeryun Kim, Liping Yan, Shin-San M. Su, Scott A. Biller and Hua YangDrug Metabolism and Disposition October 2021, 49 (10) 870-881; DOI: https://doi.org/10.1124/dmd.120.000234
de Morais, Sonia M.
- You have accessQuantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin DispositionRyota Kikuchi, William J. Chiou, Kenneth R. Durbin, John P. Savaryn, Junli Ma, Arian Emami Riedmaier, Sonia M. de Morais, Gary J. Jenkins and Daniel A.J. BowDrug Metabolism and Disposition October 2021, 49 (10) 938-946; DOI: https://doi.org/10.1124/dmd.121.000487
Durbin, Kenneth R.
- You have accessQuantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin DispositionRyota Kikuchi, William J. Chiou, Kenneth R. Durbin, John P. Savaryn, Junli Ma, Arian Emami Riedmaier, Sonia M. de Morais, Gary J. Jenkins and Daniel A.J. BowDrug Metabolism and Disposition October 2021, 49 (10) 938-946; DOI: https://doi.org/10.1124/dmd.121.000487
E
Emami Riedmaier, Arian
- You have accessQuantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin DispositionRyota Kikuchi, William J. Chiou, Kenneth R. Durbin, John P. Savaryn, Junli Ma, Arian Emami Riedmaier, Sonia M. de Morais, Gary J. Jenkins and Daniel A.J. BowDrug Metabolism and Disposition October 2021, 49 (10) 938-946; DOI: https://doi.org/10.1124/dmd.121.000487
Eng, Heather
- You have accessStatic and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and HepatocytesElaine Tseng, Heather Eng, Jian Lin, Matthew A. Cerny, David A. Tess, Theunis C. Goosen and R. Scott ObachDrug Metabolism and Disposition October 2021, 49 (10) 947-960; DOI: https://doi.org/10.1124/dmd.121.000497
F
Fan, Bin
- You have accessPreclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V. Nagaraja, Bin Fan, Luke Utley, Rene M. Lemieux, Janeta Popovici-Muller, Lenny Dang, Hyeryun Kim, Liping Yan, Shin-San M. Su, Scott A. Biller and Hua YangDrug Metabolism and Disposition October 2021, 49 (10) 870-881; DOI: https://doi.org/10.1124/dmd.120.000234
Fu, Dong
- You have accessCytochrome P450–Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-CannabidiolJessica L. Beers, Dong Fu and Klarissa D. JacksonDrug Metabolism and Disposition October 2021, 49 (10) 882-891; DOI: https://doi.org/10.1124/dmd.120.000350
G
Goosen, Theunis C.
- You have accessStatic and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and HepatocytesElaine Tseng, Heather Eng, Jian Lin, Matthew A. Cerny, David A. Tess, Theunis C. Goosen and R. Scott ObachDrug Metabolism and Disposition October 2021, 49 (10) 947-960; DOI: https://doi.org/10.1124/dmd.121.000497
Guengerich, F. Peter
- You have accessCytochrome b5 Binds Tightly to Several Human Cytochrome P450 EnzymesDonghak Kim, Vitchan Kim, Yasuhiro Tateishi and F. Peter GuengerichDrug Metabolism and Disposition October 2021, 49 (10) 902-909; DOI: https://doi.org/10.1124/dmd.121.000475
J
Jackson, Klarissa D.
- You have accessCytochrome P450–Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-CannabidiolJessica L. Beers, Dong Fu and Klarissa D. JacksonDrug Metabolism and Disposition October 2021, 49 (10) 882-891; DOI: https://doi.org/10.1124/dmd.120.000350
Jenkins, Gary J.
- You have accessQuantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin DispositionRyota Kikuchi, William J. Chiou, Kenneth R. Durbin, John P. Savaryn, Junli Ma, Arian Emami Riedmaier, Sonia M. de Morais, Gary J. Jenkins and Daniel A.J. BowDrug Metabolism and Disposition October 2021, 49 (10) 938-946; DOI: https://doi.org/10.1124/dmd.121.000487
Jia, Yudi
- You have accessIcotinib Induces Mechanism-Based Inactivation of Recombinant Human CYP3A4/5 Possibly via Heme Destruction by Ketene IntermediateChen Sun, Huimin Zhao, Wei Li, Yudi Jia, Yi Yang, Ying Peng and Jiang ZhengDrug Metabolism and Disposition October 2021, 49 (10) 892-901; DOI: https://doi.org/10.1124/dmd.121.000369
K
Kikuchi, Ryota
- You have accessQuantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin DispositionRyota Kikuchi, William J. Chiou, Kenneth R. Durbin, John P. Savaryn, Junli Ma, Arian Emami Riedmaier, Sonia M. de Morais, Gary J. Jenkins and Daniel A.J. BowDrug Metabolism and Disposition October 2021, 49 (10) 938-946; DOI: https://doi.org/10.1124/dmd.121.000487
Kim, Donghak
- You have accessCytochrome b5 Binds Tightly to Several Human Cytochrome P450 EnzymesDonghak Kim, Vitchan Kim, Yasuhiro Tateishi and F. Peter GuengerichDrug Metabolism and Disposition October 2021, 49 (10) 902-909; DOI: https://doi.org/10.1124/dmd.121.000475
Kim, Hyeryun
- You have accessPreclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V. Nagaraja, Bin Fan, Luke Utley, Rene M. Lemieux, Janeta Popovici-Muller, Lenny Dang, Hyeryun Kim, Liping Yan, Shin-San M. Su, Scott A. Biller and Hua YangDrug Metabolism and Disposition October 2021, 49 (10) 870-881; DOI: https://doi.org/10.1124/dmd.120.000234
Kim, Vitchan
- You have accessCytochrome b5 Binds Tightly to Several Human Cytochrome P450 EnzymesDonghak Kim, Vitchan Kim, Yasuhiro Tateishi and F. Peter GuengerichDrug Metabolism and Disposition October 2021, 49 (10) 902-909; DOI: https://doi.org/10.1124/dmd.121.000475
L
Ladumor, Mayur K.
- You have accessPrediction of Pregnancy-Induced Changes in Secretory and Total Renal Clearance of Drugs Transported by Organic Anion TransportersJinfu Peng, Mayur K. Ladumor and Jashvant D. UnadkatDrug Metabolism and Disposition October 2021, 49 (10) 929-937; DOI: https://doi.org/10.1124/dmd.121.000557
Lemieux, Rene M.
- You have accessPreclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V. Nagaraja, Bin Fan, Luke Utley, Rene M. Lemieux, Janeta Popovici-Muller, Lenny Dang, Hyeryun Kim, Liping Yan, Shin-San M. Su, Scott A. Biller and Hua YangDrug Metabolism and Disposition October 2021, 49 (10) 870-881; DOI: https://doi.org/10.1124/dmd.120.000234
Li, Wei
- You have accessIcotinib Induces Mechanism-Based Inactivation of Recombinant Human CYP3A4/5 Possibly via Heme Destruction by Ketene IntermediateChen Sun, Huimin Zhao, Wei Li, Yudi Jia, Yi Yang, Ying Peng and Jiang ZhengDrug Metabolism and Disposition October 2021, 49 (10) 892-901; DOI: https://doi.org/10.1124/dmd.121.000369
Lin, Jian
- You have accessStatic and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and HepatocytesElaine Tseng, Heather Eng, Jian Lin, Matthew A. Cerny, David A. Tess, Theunis C. Goosen and R. Scott ObachDrug Metabolism and Disposition October 2021, 49 (10) 947-960; DOI: https://doi.org/10.1124/dmd.121.000497
M
Ma, Junli
- You have accessQuantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin DispositionRyota Kikuchi, William J. Chiou, Kenneth R. Durbin, John P. Savaryn, Junli Ma, Arian Emami Riedmaier, Sonia M. de Morais, Gary J. Jenkins and Daniel A.J. BowDrug Metabolism and Disposition October 2021, 49 (10) 938-946; DOI: https://doi.org/10.1124/dmd.121.000487
Mao, Qingcheng
- You have accessTetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2)Xin Chen, Jashvant D. Unadkat and Qingcheng MaoDrug Metabolism and Disposition October 2021, 49 (10) 910-918; DOI: https://doi.org/10.1124/dmd.121.000505
N
Nagaraja, Nelamangala V.
- You have accessPreclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V. Nagaraja, Bin Fan, Luke Utley, Rene M. Lemieux, Janeta Popovici-Muller, Lenny Dang, Hyeryun Kim, Liping Yan, Shin-San M. Su, Scott A. Biller and Hua YangDrug Metabolism and Disposition October 2021, 49 (10) 870-881; DOI: https://doi.org/10.1124/dmd.120.000234
O
Obach, R. Scott
- You have accessStatic and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and HepatocytesElaine Tseng, Heather Eng, Jian Lin, Matthew A. Cerny, David A. Tess, Theunis C. Goosen and R. Scott ObachDrug Metabolism and Disposition October 2021, 49 (10) 947-960; DOI: https://doi.org/10.1124/dmd.121.000497
P
Peng, Jinfu
- You have accessPrediction of Pregnancy-Induced Changes in Secretory and Total Renal Clearance of Drugs Transported by Organic Anion TransportersJinfu Peng, Mayur K. Ladumor and Jashvant D. UnadkatDrug Metabolism and Disposition October 2021, 49 (10) 929-937; DOI: https://doi.org/10.1124/dmd.121.000557
Peng, Ying
- You have accessIcotinib Induces Mechanism-Based Inactivation of Recombinant Human CYP3A4/5 Possibly via Heme Destruction by Ketene IntermediateChen Sun, Huimin Zhao, Wei Li, Yudi Jia, Yi Yang, Ying Peng and Jiang ZhengDrug Metabolism and Disposition October 2021, 49 (10) 892-901; DOI: https://doi.org/10.1124/dmd.121.000369
Popovici-Muller, Janeta
- You have accessPreclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V. Nagaraja, Bin Fan, Luke Utley, Rene M. Lemieux, Janeta Popovici-Muller, Lenny Dang, Hyeryun Kim, Liping Yan, Shin-San M. Su, Scott A. Biller and Hua YangDrug Metabolism and Disposition October 2021, 49 (10) 870-881; DOI: https://doi.org/10.1124/dmd.120.000234
S
Savaryn, John P.
- You have accessQuantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin DispositionRyota Kikuchi, William J. Chiou, Kenneth R. Durbin, John P. Savaryn, Junli Ma, Arian Emami Riedmaier, Sonia M. de Morais, Gary J. Jenkins and Daniel A.J. BowDrug Metabolism and Disposition October 2021, 49 (10) 938-946; DOI: https://doi.org/10.1124/dmd.121.000487
Storelli, Flavia
- Open AccessSuccessful Prediction of Human Fetal Exposure to P-Glycoprotein Substrate Drugs Using the Proteomics-Informed Relative Expression Factor Approach and PBPK Modeling and SimulationOlena Anoshchenko, Flavia Storelli and Jashvant D. UnadkatDrug Metabolism and Disposition October 2021, 49 (10) 919-928; DOI: https://doi.org/10.1124/dmd.121.000538
Su, Shin-San M.
- You have accessPreclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V. Nagaraja, Bin Fan, Luke Utley, Rene M. Lemieux, Janeta Popovici-Muller, Lenny Dang, Hyeryun Kim, Liping Yan, Shin-San M. Su, Scott A. Biller and Hua YangDrug Metabolism and Disposition October 2021, 49 (10) 870-881; DOI: https://doi.org/10.1124/dmd.120.000234
Sun, Chen
- You have accessIcotinib Induces Mechanism-Based Inactivation of Recombinant Human CYP3A4/5 Possibly via Heme Destruction by Ketene IntermediateChen Sun, Huimin Zhao, Wei Li, Yudi Jia, Yi Yang, Ying Peng and Jiang ZhengDrug Metabolism and Disposition October 2021, 49 (10) 892-901; DOI: https://doi.org/10.1124/dmd.121.000369
T
Tateishi, Yasuhiro
- You have accessCytochrome b5 Binds Tightly to Several Human Cytochrome P450 EnzymesDonghak Kim, Vitchan Kim, Yasuhiro Tateishi and F. Peter GuengerichDrug Metabolism and Disposition October 2021, 49 (10) 902-909; DOI: https://doi.org/10.1124/dmd.121.000475
Tess, David A.
- You have accessStatic and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and HepatocytesElaine Tseng, Heather Eng, Jian Lin, Matthew A. Cerny, David A. Tess, Theunis C. Goosen and R. Scott ObachDrug Metabolism and Disposition October 2021, 49 (10) 947-960; DOI: https://doi.org/10.1124/dmd.121.000497
Tseng, Elaine
- You have accessStatic and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and HepatocytesElaine Tseng, Heather Eng, Jian Lin, Matthew A. Cerny, David A. Tess, Theunis C. Goosen and R. Scott ObachDrug Metabolism and Disposition October 2021, 49 (10) 947-960; DOI: https://doi.org/10.1124/dmd.121.000497
U
Unadkat, Jashvant D.
- Open AccessSuccessful Prediction of Human Fetal Exposure to P-Glycoprotein Substrate Drugs Using the Proteomics-Informed Relative Expression Factor Approach and PBPK Modeling and SimulationOlena Anoshchenko, Flavia Storelli and Jashvant D. UnadkatDrug Metabolism and Disposition October 2021, 49 (10) 919-928; DOI: https://doi.org/10.1124/dmd.121.000538
- You have accessPrediction of Pregnancy-Induced Changes in Secretory and Total Renal Clearance of Drugs Transported by Organic Anion TransportersJinfu Peng, Mayur K. Ladumor and Jashvant D. UnadkatDrug Metabolism and Disposition October 2021, 49 (10) 929-937; DOI: https://doi.org/10.1124/dmd.121.000557
- You have accessTetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2)Xin Chen, Jashvant D. Unadkat and Qingcheng MaoDrug Metabolism and Disposition October 2021, 49 (10) 910-918; DOI: https://doi.org/10.1124/dmd.121.000505
Utley, Luke
- You have accessPreclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V. Nagaraja, Bin Fan, Luke Utley, Rene M. Lemieux, Janeta Popovici-Muller, Lenny Dang, Hyeryun Kim, Liping Yan, Shin-San M. Su, Scott A. Biller and Hua YangDrug Metabolism and Disposition October 2021, 49 (10) 870-881; DOI: https://doi.org/10.1124/dmd.120.000234
Y
Yan, Liping
- You have accessPreclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V. Nagaraja, Bin Fan, Luke Utley, Rene M. Lemieux, Janeta Popovici-Muller, Lenny Dang, Hyeryun Kim, Liping Yan, Shin-San M. Su, Scott A. Biller and Hua YangDrug Metabolism and Disposition October 2021, 49 (10) 870-881; DOI: https://doi.org/10.1124/dmd.120.000234
Yang, Hua
- You have accessPreclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V. Nagaraja, Bin Fan, Luke Utley, Rene M. Lemieux, Janeta Popovici-Muller, Lenny Dang, Hyeryun Kim, Liping Yan, Shin-San M. Su, Scott A. Biller and Hua YangDrug Metabolism and Disposition October 2021, 49 (10) 870-881; DOI: https://doi.org/10.1124/dmd.120.000234
Yang, Yi
- You have accessIcotinib Induces Mechanism-Based Inactivation of Recombinant Human CYP3A4/5 Possibly via Heme Destruction by Ketene IntermediateChen Sun, Huimin Zhao, Wei Li, Yudi Jia, Yi Yang, Ying Peng and Jiang ZhengDrug Metabolism and Disposition October 2021, 49 (10) 892-901; DOI: https://doi.org/10.1124/dmd.121.000369
Z
Zhao, Huimin
- You have accessIcotinib Induces Mechanism-Based Inactivation of Recombinant Human CYP3A4/5 Possibly via Heme Destruction by Ketene IntermediateChen Sun, Huimin Zhao, Wei Li, Yudi Jia, Yi Yang, Ying Peng and Jiang ZhengDrug Metabolism and Disposition October 2021, 49 (10) 892-901; DOI: https://doi.org/10.1124/dmd.121.000369
Zheng, Jiang
- You have accessIcotinib Induces Mechanism-Based Inactivation of Recombinant Human CYP3A4/5 Possibly via Heme Destruction by Ketene IntermediateChen Sun, Huimin Zhao, Wei Li, Yudi Jia, Yi Yang, Ying Peng and Jiang ZhengDrug Metabolism and Disposition October 2021, 49 (10) 892-901; DOI: https://doi.org/10.1124/dmd.121.000369
In this issue
Advertisement